BME100 s2015:Group7 9amL2

From OpenWetWare
Jump to navigationJump to search
BME 100 Spring 2015 Home
People
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Photos
Wiki Editing Help

OUR TEAM

Name: Harris Tran
Name: Luke Shaffer
Name: Brandon Hansen
Name: Jaid Coronel
Name: Your name

LAB 2 WRITE-UP

Descriptive Statistics

Experiment 1
The average Inflammotin response for all human trials was 183.08225 pg/ ml.

while the standard deviation was 297.1368812 pg/ ml.

The average Inflammotin response for a 0mg dose of LPS was 3.834 pg/ml

while the standard deviation was 1.523 pg/ ml.

The average Inflammotin response for a 5mg dose of LPS was 9.932 pg/ml

while the standard deviation was 1.594 pg/ ml.

The average Inflammotin response for a 10mg dose of LPS was 61.622 pg/ml

while the standard deviation was 30.111 pg/ ml.

The average Inflammotin response for a 15mg dose of LPS was 657.941 pg/ml

while the standard deviation was 212.943 pg/ ml.

Experiment 2

The Average Inflammotin response for all rat trials was 10.81.4 pg/ ml

while the standard deviation was 5.163022801 pg/ ml.

The average inflammotin response for a 0mg dose was 10.516 pg/ml

while the standard deviation was 2.226 pg/ ml.

The average inflammotin response for a 10mg dose was 11.112 pg/ml

while the standard deviation was 7.403 pg/ ml.



Results

Experiment 1
All the groups were found to have statistically significant differences in their inflammotin responses.


Experiment 2
All the groups were found to have statistically significant differences in their inflammotin responses.





Analysis

Experiment 1

An ANOVA test was chosen because there were more than two groups to be compared. As the results show, the p value for this anova test (p<.05) indicate that the differences between the groups are statistically significant


Experiment 2

A t-test was chosen because there were only two groups to be compared. As the results show, the p value for this test (p> .05) indicates that the differences between the two groups is not statistically significant.




Summary/Discussion

The data for the human trials were all found to have statistically significant differences in their inflammotin responses. The data for the rat trials were not found to have any statistically significant differences in their inflammotin responses. However, there were two outliers in the rat study that could have skewed the data. Keeping this in mind, it is very likely that increases in LPS dosage lead to a significant change in inflammotin levels in humans and rats.